Search
Search Results
##search.searchResults.foundPlural##
-
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1354PDF: 1032HTML: 4602 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3676PDF: 1233HTML: 3882Untitled: 208Untitled: 257 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3144PDF: 1137HTML: 1482Untitled: 174Untitled: 164Untitled: 167 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3232PDF: 904HTML: 757text and figure: 225 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2006PDF: 758HTML: 3113 -
-
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1531PDF: 784HTML: 1475Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 178 -
-
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2115PDF: 755HTML: 1042Spirometry in SCA patients before transplant: 200Spirometry in SCA patients post transplant: 180 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2112PDF: 1267Html: 277 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1314PDF: 1126HTML: 115 -
-
Sickle cell disease and Bartonella spp. infection
1155PDF: 863HTML: 453 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
688PDF: 527HTML: 209 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2248PDF: 931HTML: 300 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1603PDF: 985HTML: 354 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1052PDF: 960HTML: 325 -
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1099PDF: 485HTML: 8162 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2396PDF: 1580HTML: 620 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2085PDF: 482HTML: 128 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
989PDF: 983Suppl. Files: 632HTML: 122 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7924PDF: 4102HTML: 7358 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2175PDF: 1165HTML: 2585Study of serum haptoglobin level in thalassemia: 342Figures: 175 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
871PDF: 684HTML: 317 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3368PDF: 1290HTML: 1861Fig.1: 199Fig. 2: 205







